315 related articles for article (PubMed ID: 24572429)
1. Outcome of adjuvant therapy in biliary tract cancers.
McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
[TBL] [Abstract][Full Text] [Related]
2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
3. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
4. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
6. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1].
Guettier C
Ann Pathol; 2014 Aug; 34(4):309-14. PubMed ID: 25132442
[No Abstract] [Full Text] [Related]
7. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis.
Rangarajan K; Simmons G; Manas D; Malik H; Hamady ZZ
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):684-693. PubMed ID: 31761507
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
9. [Cholangiocarcinoma].
Harder J; Blum HE
Praxis (Bern 1994); 2002 Aug; 91(34):1352-6. PubMed ID: 12233266
[TBL] [Abstract][Full Text] [Related]
10. Novel prognostic scoring system after surgery for Klatskin tumor.
Kaiser GM; Paul A; Sgourakis G; Molmenti EP; Dechêne A; Trarbach T; Stuschke M; Baba HA; Gerken G; Sotiropoulos GC
Am Surg; 2013 Jan; 79(1):90-5. PubMed ID: 23317618
[TBL] [Abstract][Full Text] [Related]
11. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
Gold DG; Miller RC; Haddock MG; Gunderson LL; Quevedo F; Donohue JH; Bhatia S; Nagorney DM
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):150-5. PubMed ID: 19297105
[TBL] [Abstract][Full Text] [Related]
14. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Gholami S; Colby S; Horowitz DP; Guthrie KA; Ben-Josef E; El-Khoueiry AB; Blanke CD; Philip PA; Kachnic LA; Ahmad SA; Rocha FG
Ann Surg Oncol; 2023 Mar; 30(3):1354-1363. PubMed ID: 36622529
[TBL] [Abstract][Full Text] [Related]
16. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
[TBL] [Abstract][Full Text] [Related]
17. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
[TBL] [Abstract][Full Text] [Related]
18. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage.
Born P; Rösch T; Brühl K; Sandschin W; Weigert N; Ott R; Frimberger E; Allescher HD; Hoffmann W; Neuhaus H; Classen M
Z Gastroenterol; 2000 Jun; 38(6):483-9. PubMed ID: 10923359
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]